Wakefield Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Sell |
33,768
-813
| -2% | -$90.1K | 1.05% | 27 |
|
|
2025
Q1 | $3.87M | Buy |
34,581
+29,020
| +522% | +$3.25M | 1.17% | 15 |
|
|
2024
Q4 | $514K | Buy |
+5,561
| New | +$514K | 0.17% | 131 |
|
|
2023
Q2 | – | Sell |
-34,548
| Closed | -$2.87M | – | 164 |
|
|
2023
Q1 | $2.87M | Buy |
34,548
+180
| +0.5% | +$14.9K | 1.19% | 22 |
|
|
2022
Q4 | $2.95M | Buy |
34,368
+29,099
| +552% | +$2.5M | 1.25% | 18 |
|
|
2022
Q3 | $325K | Sell |
5,269
-62
| -1% | -$3.82K | 0.15% | 135 |
|
|
2022
Q2 | $330K | Buy |
+5,331
| New | +$330K | 0.14% | 138 |
|
|
2019
Q4 | – | Sell |
-3,181
| Closed | -$202K | – | 170 |
|
|
2019
Q3 | $202K | Sell |
3,181
-95
| -3% | -$6.03K | 0.09% | 147 |
|
|
2019
Q2 | $221K | Buy |
+3,276
| New | +$221K | 0.09% | 145 |
|